Hemostasis Products Global Market Report 2024

Description

Hemostasis products are medical substances or devices employed to control bleeding and facilitate clotting (hemostasis) across diverse medical contexts. These products play a critical role in the management of bleeding disorders, promotion of wound healing, and ensuring the proper functioning of the body's clotting mechanisms.

The primary categories of hemostasis products include topical hemostasis products, infusible hemostasis products, and advanced hemostasis products. Topical hemostasis products encompass medical substances or materials specifically designed to halt or regulate bleeding. They find applications in various scenarios such as trauma, surgery, hemophilia, myocardial infarction, and others, with major end-users including hospitals, clinics, and others.

The hemostasis products market research report is one of a series of new reports from The Business Research Company that provides hemostasis products market statistics, including hemostasis products industry global market size, regional shares, competitors with a hemostasis products market share, detailed hemostasis products market segments, market trends and opportunities, and any further data you may need to thrive in the hemostasis products industry. This hemostasis products market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hemostasis products market size has grown strongly in recent years. It will grow from $1.59 billion in 2023 to $1.7 billion in 2024 at a compound annual growth rate (CAGR) of 7.0%. The growth observed in the historical period can be attributed to an increase in surgical procedures, a growing aging population, a rise in the incidence of hemophilia, the expansion of healthcare infrastructure, and an increased awareness of blood clotting disorders.

The hemostasis products market size is expected to see strong growth in the next few years. It will grow to $2.16 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%. The anticipated growth in the forecast period can be attributed to the increasing demand for minimally invasive surgeries, a global rise in trauma cases, the expansion of hemostasis applications in chronic diseases, a shift towards ambulatory surgical centers, and the focus on personalized medicine and biomarker research. Key trends expected in the forecast period include technological innovations in hemostasis, advancements in hemostatic technologies, a growing preference for minimally invasive procedures, an increasing incidence of chronic diseases, and a heightened focus on biodegradable hemostatic agents.

The expected increase in the prevalence of blood disorders is poised to drive the growth of the hemostasis products market in the foreseeable future. Blood disorders, or hematologic disorders, encompass various medical conditions affecting the composition, function, and behavior of blood and its components. Hemostasis products play a crucial role in managing clotting and bleeding processes associated with different blood disorders, addressing both excessive bleeding (hemorrhage) and excessive clotting (thrombosis). According to the Leukemia Foundation's June 2021 report, approximately 110,000 people in Australia were living with blood disorders in 2021, a number expected to surpass 275,000 cases by 2035 due to the rising incidence of blood cancer and disorders in the country. Thus, the growing prevalence of blood disorders is a key driver fueling the growth of the hemostasis products market.

The anticipated rise in the prevalence of cardiac disorders is expected to contribute significantly to the growth of the hemostasis products market. Cardiac disorders encompass a broad category of medical conditions affecting the heart and blood vessels. Hemostasis products play a vital role in managing bleeding associated with cardiac disorders and in preventing and treating such conditions. By minimizing blood loss, these products reduce the need for blood transfusions and potential complications related to cardiac disorders. According to the Centers for Disease Control and Prevention (CDC) in May 2023, a heart attack occurs every 40 seconds in the United States, with 805,000 Americans experiencing a heart attack each year, 605,000 of whom are facing their first episode. Therefore, the increasing prevalence of cardiac disorders is a significant driver propelling the growth of the hemostasis products market.

The hemostasis products market is expected to encounter a notable challenge in the form of off-label product usage. This practice involves utilizing hemostatic products for purposes beyond their approved indications, potentially introducing risks and uncertainties in hemostatic treatment. Off-label marketing, as highlighted by the National Library of Medicine, undermines innovation by allowing manufacturers to expand product usage without the necessary research or safety testing. This practice may pose challenges to companies that diligently conduct research and development efforts. Consequently, off-label product usage poses a hindrance to the growth of the hemostasis products market.

Major companies in the hemostasis products market are focusing on the development of innovative drugs, including the Nexpowder endoscopic hemostasis system, and obtaining approvals for a comprehensive range of active and passive hemostatic products for bleeding control. The endoscopic hemostasis system is a medical device and technique used to control bleeding in the gastrointestinal (GI) tract during endoscopic procedures. Medtronic plc, a US-based medical device company, received clearance from the U.S. Food and Drug Administration in September 2022 for the Nexpowder Endoscopic Hemostasis System, designed for the treatment of nonvariceal upper GI bleeding. This innovative hemostatic product has the potential to make a significant impact on the treatment of nonvariceal upper GI bleeding due to its ease of use, effectiveness, and good tolerability.

In July 2021, Baxter International Inc., a US-based healthcare company, acquired assets such as the Polysaccharide Hemostatic System from CryoLife Inc. for $60.8 million. This strategic acquisition aims to expand Baxter's hemostasis product portfolio, gain access to PerClot's technology, and enhance its position in the hemostasis market. CryoLife Inc., a US-based medical device company, specializes in developing and manufacturing products for hemostasis.

Major companies operating in the hemostasis products market report are Pfizer Inc., Abbott Laboratories, Thermo Fisher Scientific Inc., Medtronic plc, Johnson And Johnson Pvt. Ltd., Siemens Healthineers, Becton Dickinson and Company (BD), Stryker Corporation, Baxter International Inc., Boston Scientific Corporation, F. Hoffmann-La Roche Ltd., BBraun Melsungen AG, Fresenius Kabi AG, Zimmer Biomet Holdings Inc., Olympus Corporation, Grifols S.A., Terumo BCT Inc., Smith And Nephew plc, Ethicon Suture Laboratories, Hologic Inc., Cook Medical, Teleflex Incorporated, Integra LifeSciences Corporation, Haemonetics Corporation, Z-Medica LLC, Tricol Biomedical, Hem Con Medical Technologies Inc., Hemostasis LLC, C. R. Bard Inc., CuraMedical BV

North America was the largest region in the hemostasis products market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hemostasis products market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the hemostasis products market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The hemostasis products market consists of sales of hemostatic agents, hemostatic powders, hemostatic sponges, collagen, oxidized regenerated cellulose, gelatin, polysaccharide, flowable complex, thrombin complex, fibrin complex, synthetic sealants, and fresh frozen plasma. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hemostasis Products Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hemostasis products market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hemostasis products? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hemostasis products market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Product: Topical Hemostasis Product; Infusible Hemostasis Product; Advanced Hemostasis Product
2) By Application: Trauma; Surgery; Hemophilia; Myocardial Infarction; Other Applications
3) By End User: Hospitals; Clinics; Other End Users
Companies Mentioned: Pfizer Inc.; Abbott Laboratories; Thermo Fisher Scientific Inc.; Medtronic plc; Johnson And Johnson Pvt. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r13457

1. Executive Summary

2. Hemostasis Products Market Characteristics

3. Hemostasis Products Market Trends And Strategies

4. Hemostasis Products Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Hemostasis Products Market Size and Growth

5.1. Global Hemostasis Products Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Hemostasis Products Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Hemostasis Products Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Hemostasis Products Market Segmentation

6.1. Global Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Topical Hemostasis Product
Infusible Hemostasis Product
Advanced Hemostasis Product
6.2. Global Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Trauma
Surgery
Hemophilia
Myocardial Infarction
Other Applications
6.3. Global Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Clinics
Other End Users

7. Hemostasis Products Market Regional And Country Analysis

7.1. Global Hemostasis Products Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Hemostasis Products Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Hemostasis Products Market

8.1. Asia-Pacific Hemostasis Products Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Hemostasis Products Market

9.1. China Hemostasis Products Market Overview
9.2. China Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Hemostasis Products Market

10.1. India Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Hemostasis Products Market

11.1. Japan Hemostasis Products Market Overview
11.2. Japan Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Hemostasis Products Market

12.1. Australia Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Hemostasis Products Market

13.1. Indonesia Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Hemostasis Products Market

14.1. South Korea Hemostasis Products Market Overview
14.2. South Korea Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Hemostasis Products Market

15.1. Western Europe Hemostasis Products Market Overview
15.2. Western Europe Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Hemostasis Products Market

16.1. UK Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Hemostasis Products Market

17.1. Germany Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Hemostasis Products Market

18.5. France Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.6. France Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.7. France Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Hemostasis Products Market

19.9. Italy Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.10. Italy Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.11. Italy Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Hemostasis Products Market

20.13. Spain Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.14. Spain Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.15. Spain Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Hemostasis Products Market

21.1. Eastern Europe Hemostasis Products Market Overview
21.2. Eastern Europe Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Hemostasis Products Market

22.1. Russia Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Hemostasis Products Market

23.1. North America Hemostasis Products Market Overview
23.2. North America Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Hemostasis Products Market

24.1. USA Hemostasis Products Market Overview
24.2. USA Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Hemostasis Products Market

25.1. Canada Hemostasis Products Market Overview
25.2. Canada Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Hemostasis Products Market

26.1. South America Hemostasis Products Market Overview
26.2. South America Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Hemostasis Products Market

27.1. Brazil Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Hemostasis Products Market

28.1. Middle East Hemostasis Products Market Overview
28.2. Middle East Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Hemostasis Products Market

29.1. Africa Hemostasis Products Market Overview
29.2. Africa Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Hemostasis Products Market Competitive Landscape And Company Profiles

30.1. Hemostasis Products Market Competitive Landscape
30.2. Hemostasis Products Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Abbott Laboratories
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Thermo Fisher Scientific Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Medtronic plc
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Johnson And Johnson Pvt. Ltd.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Hemostasis Products Market Other Major And Innovative Companies

31.1. Siemens Healthineers
31.2. Becton Dickinson and Company (BD)
31.3. Stryker Corporation
31.4. Baxter International Inc.
31.5. Boston Scientific Corporation
31.6. F. Hoffmann-La Roche Ltd.
31.7. BBraun Melsungen AG
31.8. Fresenius Kabi AG
31.9. Zimmer Biomet Holdings Inc.
31.10. Olympus Corporation
31.11. Grifols S.A.
31.12. Terumo BCT Inc.
31.13. Smith And Nephew plc
31.14. Ethicon Suture Laboratories
31.15. Hologic Inc.

32. Global Hemostasis Products Market Competitive Benchmarking

33. Global Hemostasis Products Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Hemostasis Products Market

35. Hemostasis Products Market Future Outlook and Potential Analysis

35.1 Hemostasis Products Market In 2028 - Countries Offering Most New Opportunities
35.2 Hemostasis Products Market In 2028 - Segments Offering Most New Opportunities
35.3 Hemostasis Products Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer